Tredegar Corporation TG
5.42 USD -0.23 (-4.07%)
Regular-session close
5.42 0.00 0.00%
After hours · Nov 20, 4:01 PM ET
5.40 Day range 5.63
5.39 52-week range 10.35
- YTD
- -24.51%
- 1 year
- -30.87%
News
gurufocus.com TRYNGOLZA™ (olezarsen) approved in the EU for severe hypertriglyceridemia (sHTG) [url="]Ionis Pharmaceuticals, Inc.[/url] (Nasdaq: IONS) today announced that the European Commission (EC) has approved TRYNGOLZA⢠(olezarsen) as an adjunct to
defenseworld.net Head-To-Head Contrast: Tredegar (NYSE:TG) vs. Ivanhoe Mines (OTCMKTS:IVPAF) Tredegar (NYSE: TG - Get Free Report) and Ivanhoe Mines (OTCMKTS:IVPAF - Get Free Report) are both materials companies, but which is the better investment? We will contrast the two companies based on…
zacks.com TG Stock Tumbles 19% As It Incurs Q3 Loss on Soft Construction Demand Tredegar's Q3 earnings per share turn negative due to lower aluminum shipments, weak films demand and higher input costs, while growing TSLOTS shipments and expected restructuring benefits offer…
gurufocus.com Arrowhead Pharmaceuticals Presents Plozasiran Data Highlighting Sustained Triglyceride Reductions and Reduced Acute Pancreatitis Rates Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented results on two of the RNA interference (RNAi) based therapies in its cardiometabolic pipeline atbenzinga.com Tredegar Q3 Adj. EPS $(0.04) Down From $0.26 YoY, Sales $177.270M Up From $162.470M YoY Tredegar (NYSE:TG) reported quarterly losses of $(0.04) per share. This is a 115.38 percent decrease over earnings of $0.26 per share from the same period last year. The company reported $177.270…
businesswire.com Tredegar Reports Third Quarter 2026 Results RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Corporation (NYSE:TG, also the “Company” or “Tredegar”) today reported third quarter financial results for the period ended September 30, 2026. CEO Commentary…
businesswire.com Tredegar Plans to Release Third Quarter 2026 Financial Results on November 6, 2026 RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Corporation (NYSE:TG) plans to release financial results for the third quarter of 2026 on November 6, 2026. About Tredegar Tredegar Corporation is an…
zacks.com 2 Stocks That May Benefit from Data Center Build-out TG and MCEM may benefit from data center construction.
businesswire.com Tredegar Appoints Cindy Yao as Vice President, Chief Financial Officer and Treasurer RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Appoints Cindy Yao as Chief Financial Officer.
gurufocus.com Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia [url="]Arrowhead Pharmaceuticals, Inc.[/url] (NASDAQ: ARWR) today announced interim topline data from a Phase 1/2a clinical trial of ARO-DIMER-PA, the company's
businesswire.com Tredegar Announces Departure of Kevin Donnelly, Executive Vice President, General Counsel and Corporate Secretary RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Corporation (NYSE:TG) today announced that Kevin C. Donnelly, Executive Vice President, General Counsel and Corporate Secretary, will resign from the Company,…
businesswire.com Tredegar Provides Update on One Tredegar Transformation RICHMOND, Va.--(BUSINESS WIRE)--One Tredegar Transformation Update.
defenseworld.net BlackRock Inc. Purchases New Position in Tredegar Corporation $TG BlackRock Inc. purchased a new stake in Tredegar Corporation (NYSE: TG) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional…
defenseworld.net Connor Clark & Lunn Investment Management Ltd. Buys New Position in Tredegar Corporation $TG Connor Clark and Lunn Investment Management Ltd. bought a new stake in Tredegar Corporation (NYSE: TG) during the undefined quarter, according to the company in its most recent 13F filing with the…
gurufocus.com Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented results from the pivotal Phase 3 SHASTA-3 and SHASTA-4 studies of plozasiran in adults with sever
businesswire.com Tredegar Announces Election of Ana Dutra to Board of Directors RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR ANNOUNCES ELECTION OF ANA DUTRA TO BOARD OF DIRECTORS.
zacks.com Tredegar Q2 Earnings Rise Y/Y on Aluminum Extrusions Gains TG's Q2 earnings per share and sales improve year over year as Aluminum Extrusions benefit from favorable metal dynamics and rising TSLOTS demand, offsetting softer volumes and weaker High…
defenseworld.net Tredegar (NYSE:TG) Share Price Crosses Above 200 Day Moving Average – Here’s Why Tredegar Corporation (NYSE: TG - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $8.29 and traded as high…
businesswire.com Tredegar Reports Second Quarter 2026 Results RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS.
businesswire.com Tredegar Plans to Release Second Quarter 2026 Financial Results on August 7, 2026 RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR PLANS TO RELEASE SECOND QUARTER 2026 FINANCIAL RESULTS ON AUGUST 7, 2026.
businesswire.com Tredegar Announces the Retirement of Frasier W. Brickhouse II, Chief Financial Officer, Treasurer and Vice President, Effective September 1, 2026 RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR ANNOUNCES THE RETIREMENT OF FRASIER W. BRICKHOUSE II, CHIEF FINANCIAL OFFICER, TREASURER AND VICE PRESIDENT, EFFECTIVE SEPTEMBER 1, 2026.
